Skip to content

Clinical trials

Phase 3 Inflammatory Bowel Diseases trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Phase: Phase 3 Country / region: Poland Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20091
20102
20115
20121
20151
20182
20201
20212
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated5
Recruiting3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC5
Eli Lilly and Company4
GlaxoSmithKline2
InDex Pharmaceuticals2
AstraZeneca1
Forest Laboratories1
Janssen Biotech, Inc.1
Merck Sharp & Dohme LLC1
Ocera Therapeutics1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases20
Crohn Disease11
Colitis, Ulcerative9
Colitis3
Gastrointestinal Diseases3
Colonic Diseases1
Fistula1
Intestinal Fistula1
Proctitis1
Proctocolitis1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.